Herbert Irving Comprehensive Cancer Center at New York-Presbyterian/Columbia University Medical Center | oneAMYLOIDOSISvoice
Academic & Health Care Centers

Herbert Irving Comprehensive Cancer Center at New York-Presbyterian/Columbia University Medical Center

Irving Cancer Research Center
1130 St. Nicholas Avenue
2nd Floor, Room 201
New York, New York, United States
Phone   Web  
The Herbert Irving Comprehensive Cancer Center (HICCC) of Columbia University is the University’s organizational structure for the conduct of basic, clinical and population-based cancer research and patient care. Patients across the nation and worldwide come to the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian/Columbia University Medical Center for truly individualized care.
 
Amyloidosis can be difficult to diagnose because its symptoms often mimic those of other conditions. Although it is a very uncommon, it is likely under-diagnosed. Physicians at the Herbert Irving Cancer Center place a high priority on diagnosing and treating patients in the early stage of the disease before organs are seriously affected.
 
Since amyloidosis can affect so many different organs, it is critical to have a multidisciplinary team with specialized experience in all of the different organ systems. At this center, we bring together experts in many different fields to consult with the patient, during a single appointment, thereby minimizing the number of hospital visits needed.
 
Our pathologists employ the latest technology to evaluate biopsy samples including dual immunostaining, congo red staining, and computer image analysis. The increased sensitivity of this testing platform allows us to make a definitive diagnosis of amyloidosis and helps us to determine an appropriate therapy.